Parkinson's Disease in 2020 with Roger Barker

Pager

Content provided by George Milner, Stan Dale, George Milner, and Stan Dale. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by George Milner, Stan Dale, George Milner, and Stan Dale or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3+ y ago 54:13

MP3•Episode home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on December 10, 2023 12:11 (5M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

In this episode, Dr Roger Barker joins us to discuss our current understanding of Parkinson's disease.
The first half of the conversation focuses on the disease process. Is Parkinson's a single disease or a group of connected diseases? How might this difference affect our thinking surrounding Parkinson's?
The discussion then switches to the development of cell and gene therapies for Parkinson's. The unique challenges of a cell therapy for the brain, as well as the efficacy of a neurotrophic factor 'GDNF', are both discussed.
Dr Barker is the professor of clinical neuroscience at the University of Cambridge, and a consultant neurologist at Addenbrooke’s hospital in Cambridge. His lab at the John van Geest Centre for Brain Repair is focused on better understanding both Parkinson's and Huntington's disease, as well as on developing therapies to treat these diseases.
More information can be found at the lab's website: http://www.thebarkerwilliamsgraylab.co.uk/

71 episodes

#Science #Tech #Fitness #Biology #Medicine #George Milner, Stan Dale #George Milner #Stan Dale #Biotechnology #Medical Ethics #Life Sciences